Floatz logo

Atg-010

1. Relapsed Ovarian Cancer 2. Metastatic Ovarian Cancer 3. Endometrial Cancer 4. Cervical Cancer

Qi ZhouPhase 2Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the 1. Relapsed Ovarian Cancer 2. Metastatic Ovarian Cancer 3. Endometrial Cancer 4. Cervical Cancer cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
Qi Zhou
Phase 2CCC
ONATASERTIB
Qi Zhou
Phase 2CC

Same molecule, other indications

Atg-010 is also rated in:

relapsed/refractory diffuse large B-cell lymphomaDormant
CCC
Indicative ·
49 / 100
View asset →
plasma cell myelomaDormant
CC
Indicative ·
45 / 100
View asset →
NK/T-cell LymphomaDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →